Vincent Evangelista, DPM
Primary Podiatric Medicine · Ozone Park, NYNPI 1932152352
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $609 and has fallen 79.7% since, to $123 in 2024.
Across 36 payments — averaging $49.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$404
- Sandoz$389
- Medtronic$206
- Amgen$159
- Cardiovascular Systems Inc.$130
- Smith+Nephew$125
- plus $370 from 4 others
What the payments were for
- Food & beverage$1,784100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 3 | $404 |
| Sandoz | 18 | $389 |
| Medtronic | 4 | $206 |
| Amgen | 5 | $159 |
| Cardiovascular Systems Inc. | 1 | $130 |
| Smith+Nephew | 1 | $125 |
| Lifenet Health | 1 | $113 |
| GRT US Holding, Inc. | 1 | $104 |
| Cagent Vascular Inc | 1 | $86 |
| AbbVie | 1 | $67 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RAYOS$300
- Supera peripheral stent system$266
- SUPERA$138
- Diamondback Peripheral$130
- Santyl$125
- REGRANEX$125
- Oasis$125
- TheraGenesis Wound Matrix$113
- ClosureFast$108
- Qutenza$104
How this compares
$1,784 in reported general payments places this provider in the 75th percentile of 85 primary podiatric medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 291 | $9,136 |
| Clotrimazole | 102 | $5,222 |
| Doxepin Hcl | 30 | $5,115 |
| Ketoconazole | 112 | $3,637 |
| Celecoxib | 51 | $3,047 |
| Diclofenac Sodium | 83 | $1,636 |
| Ammonium Lactate | 130 | $1,621 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 49 | $1,060 |
| Mupirocin | 149 | $1,044 |
| Colchicine | 22 | $868 |
| Lidocaine Hcl ViscousLidocaine Hcl | 11 | $683 |
| Meloxicam | 15 | $633 |
| Ciclopirox | 11 | $608 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 50 | $385 |
| Nystatin | 11 | $276 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Ozone Park
- Anthony IorioNorth Salem$177K
- Brian StraussYonkers$20K
- Martin WendelkenBronx$14K
- Nicholas MegdanisBayside$12K
- Carlos SilvaWoodhaven$5K
- Edgard NauNew York$5K
- Roy DefrancisCheektowaga$4K
- Allen FungStaten Island$4K
- Lina DobronevskyManhasset$4K
- Michael MerensteinBronx$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.